Landscapes / Companies
Grit Biotechnology not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
3 in Phase 2
2 in Phase 1
Drugs
5
in active trials · 6 in all
Trials
7 active
10 since 2021
Drugs5
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 2 | 31 Jan 2027Phase 2 trial completes | |||
| Next date | 31 Jan 2027 · Phase 2 trial completes | ||||
| Also tested for | Solid Tumors, Adult, Recurrent or Metastatic Cervical Cancer | ||||
| Open drug page | |||||
— |
Phase 1/2 | 30 Dec 2027Phase 1/2 trial completes | |||
| Next date | 30 Dec 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Solid Tumors, Advanced Solid Tumors Cancer | ||||
| Open drug page | |||||
— |
Phase 1/2 | 17 Apr 2028Phase 1/2 trial completes | |||
| Next date | 17 Apr 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Hematological Malignancy (Leukemia- Lymphoma), Neurological Autoimmune Diseases | ||||
| Open drug page | |||||
— |
Phase 1 | 7 Dec 2027Phase 1 trial completes | |||
| Next date | 7 Dec 2027 · Phase 1 trial completes | ||||
| Also tested for | Advanced Clear Renal Cell Carcinoma, Adult | ||||
| Open drug page | |||||
— |
Phase 1 | 31 Dec 2027Phase 1 trial completes | |||
| Next date | 31 Dec 2027 · Phase 1 trial completes | ||||
| Also tested for | Solid Tumors, Adult | ||||
| Open drug page | |||||
About
- No active trial
- GTE001
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021